These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 7053045)

  • 21. Pathogenesis of hepatic encephalopathy in acute liver failure.
    Vaquero J; Chung C; Cahill ME; Blei AT
    Semin Liver Dis; 2003 Aug; 23(3):259-69. PubMed ID: 14523679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tryptophan in hepatic encephalopathy].
    Esquivel López A; Austria Mireles R; Coronado Perdomo D
    Rev Gastroenterol Mex; 1983; 48(2):91-4. PubMed ID: 6622904
    [No Abstract]   [Full Text] [Related]  

  • 23. Parenteral application of a special amino acid solution in the treatment of severe hepatic encephalopathy.
    Reiter HJ; Bode JC
    Z Gastroenterol; 1978 Jul; 16(7):457-64. PubMed ID: 685343
    [No Abstract]   [Full Text] [Related]  

  • 24. Brain energy metabolism in hepatic coma.
    Maiolo AT; Porro GB; Galli C; Sessa M; Polli EE
    Exp Biol Med; 1971; 4():52-70. PubMed ID: 5162460
    [No Abstract]   [Full Text] [Related]  

  • 25. L-dopa and hepatic encephalopathy.
    Loiudice TA; Tulman A; Buhac I
    N Y State J Med; 1979 Mar; 79(3):364-6. PubMed ID: 284212
    [No Abstract]   [Full Text] [Related]  

  • 26. [Countermeasures for hepatic encephalopathy complicated with liver cirrhosis].
    Watanabe A
    Nihon Naika Gakkai Zasshi; 1991 Oct; 80(10):1625-30. PubMed ID: 1774529
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of amino acids in hepatic encephalopathy.
    Battistin L; Zanchin G
    Prog Clin Biol Res; 1980; 39():315-26. PubMed ID: 6105674
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of hepatic encephalopathy. Changes in the cerebrospinal fluid concentration of catecholamine neurotransmitters, ammonia and amino acids in the course of an infusion treatment with branched-chain amino acids].
    Rössle M; Herz R; Lehmann G; Luft M; Gerok W
    Infusionsther Klin Ernahr; 1982 Oct; 9(5):256-8. PubMed ID: 7141673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography.
    Keiding S; Sørensen M; Bender D; Munk OL; Ott P; Vilstrup H
    Hepatology; 2006 Jan; 43(1):42-50. PubMed ID: 16374868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neurologic complications of liver diseases].
    Wewalka F
    Wien Z Nervenheilkd Grenzgeb; 1971; 29(1):95-106. PubMed ID: 4256005
    [No Abstract]   [Full Text] [Related]  

  • 31. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.
    Marchesini G; Fabbri A; Bianchi G; Brizi M; Zoli M
    Hepatology; 1996 May; 23(5):1084-92. PubMed ID: 8621138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatic encephalopathy and magnesium deficiency states].
    Pawlak J
    Wiad Lek; 1975 Jan; 28(2):103-5. PubMed ID: 1089347
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy].
    Chen MF; Li RC; Chen CH; Gao XC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):718-9, 722. PubMed ID: 15958319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Amino acid metabolism in hepatic encephalopathy].
    Szostak D
    Wiad Lek; 1988 Mar; 41(5):327-35. PubMed ID: 3218243
    [No Abstract]   [Full Text] [Related]  

  • 35. [Advances in research on mechanisms of hepatic encephalopathy].
    Wang XG; Huang CT
    Zhonghua Wai Ke Za Zhi; 1989 Oct; 27(10):604-6. PubMed ID: 2698790
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of 3,4-dihydroxyphenylalanine (levodopa) in hepatic coma].
    González-Posada J; Hernández-Peniche J; Tirado-Arroyave S
    Arch Invest Med (Mex); 1972; 3(1):1-6. PubMed ID: 5037838
    [No Abstract]   [Full Text] [Related]  

  • 37. [The treatment of hepatic encephalopathy with Hepa-Mertz].
    Podymova SD; Bueverov AO; Nadinskaia MIu
    Ter Arkh; 1995; 67(6):45-7. PubMed ID: 7667779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heterologous pig liver perfusion in hepatic coma].
    Flatmark A; Aune S; Otnes B; Nesbakken R; Ro J; Schistad G; Lie M; Raeder M; Jakobsen A; Skulberg P; Lilleaasen P; Gjone E
    Tidsskr Nor Laegeforen; 1969 Jun; 89(11):809-13. PubMed ID: 5793594
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prevention and therapy of portosystemic encephalopathy].
    Schmid M
    Schweiz Rundsch Med Prax; 1985 Sep; 74(36):954-7. PubMed ID: 2867591
    [No Abstract]   [Full Text] [Related]  

  • 40. Perspectives in hepatic encephalopathy.
    Hoyumpa AM; Schenker S
    J Lab Clin Med; 1982 Oct; 100(4):477-87. PubMed ID: 6126512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.